Kristen Sheppard | Vice President of Investor Relations |
John Butler | President and Chief Executive Officer |
Jason Amello | Chief Financial Officer |
Eric Joseph | JP Morgan |
Nicole Gabreski | Piper Jaffray |
David Lebowitz | Morgan Stanley |
Robert Hazlett | BTIG |
Alexandre Bouilloux | Mizuho Securties |
Chad Jason | Needham & Company |
Ed Arce | H.C. Wainwright |
Good day, ladies and gentlemen, and welcome to the Akebia Therapeutics Second Fiscal Year 2019 Financial Results and Business Highlights Conference Call.
As a reminder, this call is being recorded. Later we will conduct the question-and-answer session and instructions will follow at that time. [Operator Instructions]
I would now like to introduce your host for today's conference, Kristen Sheppard.